The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: A case series and review of the literature

Stroke

Volumn 43, Issue 2, 2012, Pages 412-416

  Edwards, Nancy J ^a   Kamel, Hooman ^b   Josephson, S Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

intracranial aneurysm; thrombolysis; tissue type plasminogen activator

Indexed keywords

ONYX COPOLYMER; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FISHER EXACT TEST; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROIMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL ANEURYSM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856504237     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.634147     Document Type: Article

References (21)

1. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Adeoye O, Hornung R, Khatri Pooja, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: A doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952-1955.
3. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010;5:406-409.
4. De Silva DA, Manzano J, Chang HM, Wong MC. Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology. 2011;76:1838-1840.
5. Hope JK, Wilson JL, Thomson FJ. Three-dimensional CT angiography in the detection and characterization of intracranial berry aneurysms. AJNR Am J Neuroradiol. 1996;3:439-445. (Pubitemid 26101945)
6. Aleu A, Mellado P, Lichy C, Kohrmann M, Schellinger P. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke. 2007;38:417-422. (Pubitemid 46184319)
7. Lagares A, Gomez PA, Lobato RD, Alen JF, Campollo J, Benito-Leon J. Cerebral aneurysm rupture after rtPA thrombolysis for acute myocardial infarction. Surg Neurol. 1999;52:623-626. (Pubitemid 30045625)
8. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251. (Pubitemid 28470336)
9. Kane I, Sandercock P, Thomas B. Can patients with unruptured intracranial aneurysms be treated with thrombolysis? Cerebrovasc Dis. 2005; 20:51-52. (Pubitemid 41003638)
10. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612-2618. (Pubitemid 47329647)
11. Kim J, Park M, Yoon W, Cho K. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke. J Neuroimaging. Epub ahead of print December 9, 2010. DOI: 10.1111/j.1552-6569.2010.00560.x.
12. D'Olhaberriague L, Joshi N, Chaturvedi S, Mitsias P, Coplin W, Lewandowski C, et al. Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms. J Stroke Cerebrovasc Dis. 2000;9:181-184. (Pubitemid 30480495)
13. Matsuzaki T, Yoshino A, Sakatani K, Katayama Y. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report. J Stroke Cerebrovasc Dis. 2011;20:269-272.
14. Yoneda Y, Yamamoto S, Hara Y, Yamashita H. Unruptured cerebral aneurysm detected after intravenous tissue plasminogen activator for stroke. Case report. Neurology. 2009;1:20-23.
15. Desai JA, Jin AY, Melanson M. IV thrombolysis in stroke from a cavernous carotid aneurysm to artery embolus. Can J Neurol Sci. 2011; 38:352-353.
16. Oh YS, Lee SJ, Shon YM, Yang DW, Kim BS, Cho AH. Incidental unruptured intracranial aneurysms in patients with acute ischemic stroke. Cerebrovasc Dis. 2008;26:650-653.
17. Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke. 1998;29: 251-256. (Pubitemid 28046972)
18. Rammos SK, Neils DM, Fraser K, Klopfenstein JD. Anterior communicating artery aneurysm rupture after intravenous thrombolysis for acute middle cerebral artery thromboembolism. Neurosurgery. Epub ahead of print July 25, 2011. PMID: 21796012.
19. Juvela S, Porras M, Heiskanen O. Natural history of unruptured intracranial aneurysms: A long-term follow-up study. J Neurosurg. 1993;79: 174-182. (Pubitemid 23215832)
20. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N Engl J Med. 1998;339:1725-1733.
21. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risk of surgical and endovascular treatment. Lancet. 2003;362:103-110.